immune globulin
Sponsors
National Center for Research Resources (NCRR), Mayo Clinic, IWK Health Centre, University of Texas, National Institute of Neurological Disorders and Stroke (NINDS)
Conditions
AsthmaDiabetic NeuropathiesGuillain-Barre SyndromeHereditary Inclusion Body MyopathyMultiple SclerosisMyasthenia GravisPertussisPolyradiculoneuropathy, Chronic Inflammatory Demyelinating
Phase 1
Phase 3
Intravenous Pertussis Immune Globulin in Patients With Severe Childhood Pertussis Infection
CompletedNCT00004422
Start: 1997-08-31End: 2002-09-30Target: 174Updated: 2015-03-25
Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy
CompletedNCT00004286
Start: 1996-02-29End: 1999-11-30Target: 120Updated: 2005-06-24
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Multiple Sclerosis
CompletedNCT00004744
Start: 1993-02-28Target: 76Updated: 2008-09-09
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflammatory Demyelinating Polyneuropathy
CompletedNCT00004772
Start: 1992-09-30Target: 90Updated: 2005-06-24
IVIG Treatment for Asthmatic Patients With IgG Subclass Deficiency
NCT01992328
Start: 2013-12-31End: 2017-01-31Target: 30Updated: 2016-05-02
Unknown Phase
Randomized Study of Intravenous Immunoglobulin (IVIg) in Patients With Subacute Proximal Diabetic Neuropathy
TerminatedNCT00004407
Start: 1998-02-28End: 2000-03-31Target: 75Updated: 2015-03-25
Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis
TerminatedNCT00004682
Start: 1995-03-31End: 1999-03-31Target: 100Updated: 2015-03-25
Randomized Study of Plasmapheresis or Human Immunoglobulin Infusion in Childhood Guillain-Barre Syndrome
TerminatedNCT00004833
Start: 1995-07-31End: 2002-11-30Target: 170Updated: 2015-04-07